Kimberly Camp
Adult Health · Durham, NCNPI 1538499843
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $95,605 of the $147,377 with a category attached, or 64.9%. GSK accounts for 65.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $75,271 and has fallen 99.1% since, to $707 in 2025. Among adult health clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 215 payments — averaging $685.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$97K
- AstraZeneca$39K
- Merck$8K
- Genmab U.S., Inc.$1K
- Immunogen, Inc.$902
- AbbVie$750
- plus $593 from 5 others
What the payments were for
- Consulting fees$14,52510%
- Speaking & faculty fees$95,60565%
- Travel & lodging$30,76321%
- Food & beverage$6,4844%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 117 | $96,718 |
| AstraZeneca | 56 | $39,051 |
| Merck | 20 | $8,158 |
| Genmab U.S., Inc. | 4 | $1,205 |
| Immunogen, Inc. | 5 | $902 |
| AbbVie | 7 | $750 |
| Seagen Inc. | 2 | $214 |
| G1 Therapeutics, Inc. | 1 | $125 |
| Sanofi | 1 | $118 |
| ADC Therapeutics America, Inc. | 1 | $116 |
| Abbott | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$147,377 in reported general payments places this provider in the 95th percentile of 614 adult health providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 12 | $148 |
| Ondansetron Hcl | 16 | $74 |
Paid to pharmacies, not to this prescriber.
Other adult health in Durham
- Ann ShumDurham$35K
- Stephanie YatesDurham$19K
- Donna AdamsDurham$10K
- Yasmin MathlinDurham$8K
- Joy CurryDurham$5K
- Shannon GrahamDurham$5K
- Robert DodgeRaleigh$311K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
- Felicia RichardsonGreenville$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.